Beta 2-microglobulin studies in endemic Balkan nephropathy.

Area of Science:

• Nephrology
• Environmental Medicine
• Epidemiology

Background:

• Balkan Endemic Nephropathy (BEN) diagnosis is challenging due to insidious onset and nonspecific kidney changes.
• Current clinical and laboratory diagnostic methods for BEN lack universal acceptance.
• Early detection of BEN is crucial for effective management and understanding its progression.

Purpose of the Study:

• To investigate the frequency of increased urinary beta 2-microglobulin (U beta 2m) in at-risk populations for BEN.
• To compare U beta 2m levels in endemic BEN villages versus control populations.
• To assess U beta 2m as a potential early diagnostic marker for BEN.

Main Methods:

• Population samples from endemic and control villages were classified as healthy, suspect, or diseased.
• Urinary beta 2-microglobulin (U beta 2m) levels were measured.
• Clinical and laboratory findings were used for BEN diagnosis.

Main Results:

• 87% of clinically diagnosed BEN patients showed increased U beta 2m.
• The prevalence of kidney disease was 13.4 times higher in the endemic village sample.
• Healthy individuals in endemic areas had a 6.4 times higher chance of tubular proteinuria.

Conclusions:

• Increased U beta 2m is a significant finding in individuals with BEN.
• Elevated U beta 2m in healthy individuals from endemic areas suggests early exposure to a nephrotoxic agent.
• U beta 2m testing shows promise as an early indicator for BEN and exposure to causative nephrotoxins.